Dynamic Wealth Strategies’s Pacific Biosciences PACB Stock Holding History

Dynamic Wealth Strategies’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.82K	Hold	1,678	–	–	﹤0.01%	277
2026 Q1	$2.21K	Hold	1,678	–	–	﹤0.01%	268
2025 Q4	$3.14K	Hold	1,678	–	–	﹤0.01%	237
2025 Q3	$2.15K	Hold	1,678	–	–	﹤0.01%	232
2025 Q2	$2.08K	Hold	1,678	–	–	﹤0.01%	224
2025 Q1	$1.98K	Buy	+1,678	New	+$2.57K	﹤0.01%	224
2024 Q4	–	Sell	-1,678	Closed	-$3K	–	181
2024 Q3	$3K	Hold	1,678	–	–	﹤0.01%	220
2024 Q2	$2K	Hold	1,678	–	–	﹤0.01%	232
2024 Q1	$6K	Hold	1,678	–	–	0.01%	226
2023 Q4	$16.5K	Buy	+1,678	New	+$13.7K	0.02%	181

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dynamic Wealth Strategies's PACB Position: Q2 2026 in Review

Dynamic Wealth Strategies held its Pacific Biosciences (PACB) position steady in Q2 2026 at 1,678 shares worth $2.82K. The position accounts for ﹤0.01% of the portfolio, ranked #277.

Dynamic Wealth Strategies first reported a position in PACB in Q4 2023 and has held it in 10 quarters since. The position peaked at $16.5K in Q4 2023. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Dynamic Wealth Strategies held 1,678 shares of Pacific Biosciences worth $2.82K as of Q2 2026.
Dynamic Wealth Strategies left its Pacific Biosciences share count unchanged in Q2 2026.
Pacific Biosciences made up ﹤0.01% of Dynamic Wealth Strategies's portfolio in Q2 2026, its #277 holding.
Dynamic Wealth Strategies first reported a position in Pacific Biosciences in Q4 2023 and has held it in 10 quarters since.
Dynamic Wealth Strategies's Pacific Biosciences position peaked at $16.5K in Q4 2023.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Dynamic Wealth Strategies's 13F filing for Q2 2026, filed 23 Jul 2026.